Emre Ertin

Tegosens, Inc. is a medical technology company based in Columbus, OH. Over 60 million people worldwide are affected by heart failure, causing over 1 million hospitalizations every year in the US alone. Tegosens is developing a low power radio frequency imaging sensor for monitoring heart failure and detecting fluid retention. The sensor is an investigational device and is limited by federal law to investigational use. It is designed to be used by qualified investigators only. Existing heart failure diagnosis solutions are expensive, invasive, and unreliable. The company was founded by Emre Ertin, Abraham Joseph, Flavio Lobato, and William T. Abraham. Abraham Joseph has been the CEO since incorporation.

Tegosens, Inc. is a medical technology company based in Columbus, OH. Over 60 million people worldwide are affected by heart failure, causing over 1 million hospitalizations every year in the US alone. Tegosens is developing a low power radio frequency imaging sensor for monitoring heart failure and detecting fluid retention. The sensor is an investigational device and is limited by federal law to investigational use. It is designed to be used by qualified investigators only. Existing heart failure diagnosis solutions are expensive, invasive, and unreliable. The company was founded by Emre Ertin, Abraham Joseph, Flavio Lobato, and William T. Abraham. Abraham Joseph has been the CEO since incorporation.

Tegosens, Inc. is a medical technology company based in Columbus, OH. Over 60 million people worldwide are affected by heart failure, causing over 1 million hospitalizations every year in the US alone. Tegosens is developing a low power radio frequency imaging sensor for monitoring heart failure and detecting fluid retention. The sensor is an investigational device and is limited by federal law to investigational use. It is designed to be used by qualified investigators only. Existing heart failure diagnosis solutions are expensive, invasive, and unreliable. The company was founded by Emre Ertin, Abraham Joseph, Flavio Lobato, and William T. Abraham. Abraham Joseph has been the CEO since incorporation.

Tegosens, Inc. is a medical technology company based in Columbus, OH. Over 60 million people worldwide are affected by heart failure, causing over 1 million hospitalizations every year in the US alone. Tegosens is developing a low power radio frequency imaging sensor for monitoring heart failure and detecting fluid retention. The sensor is an investigational device and is limited by federal law to investigational use. It is designed to be used by qualified investigators only. Existing heart failure diagnosis solutions are expensive, invasive, and unreliable. The company was founded by Emre Ertin, Abraham Joseph, Flavio Lobato, and William T. Abraham. Abraham Joseph has been the CEO since incorporation.